Skip to main content
SpringerLink
Log in

Genetic Heterogeneity in Adrenal Insufficiency

  • Living reference work entry
  • First Online:
Polyendocrine Disorders and Endocrine Neoplastic Syndromes

Part of the book series: Endocrinology ((ENDOCR))

  • 116 Accesses

Abstract

Genetic forms of primary adrenal insufficiency (AI) present clinical heterogeneity, variable modes of inheritance, and association with several clinical pictures. Congenital adrenal hyperplasia (CAH) comprises a wide group of autosomal recessive enzymatic disorders, impairing glucocorticoid, mineralocorticoid, and/or androgen biosynthesis. The most frequent form of CAH is due to 21-hydroxylase deficiency. Adrenoleukodystrophy is an X-linked progressive metabolic disorder, characterized by very long chain fatty acids accumulation with cytotoxic effects on adrenal and neural cells. Adrenal hypoplasia congenita is an X-linked disorder characterized by fetal alterations affecting adrenal glands, mainly leading to neonatal AI. Familial glucocorticoid deficiency is an autosomal recessive disease caused by multiple genetic alterations and characterized by unresponsiveness of the adrenal cortex to adrenocorticotropic hormone (ACTH) stimulation, with consequent isolated cortisol deficiency. Allgrove syndrome, a specific form of adrenal unresponsiveness to ACTH, is a rare autosomal recessive syndrome due to DNA repair defects, in which the triad AI, alachrymia, and achalasia are usually present. Aldosterone synthase deficiency is an autosomal recessive enzymatic disorder of the mineralocorticoid pathway, leading to mineralocorticoid deficiency. Primary generalized glucocorticoid resistance is a sporadic or familial form of peripheral insensitivity to glucocorticoids, either partial or generalized, caused by mutations in the glucocorticoid receptor. Type 1 pseudohypoaldosteronism is an inherited form of mineralocorticoid resistance, which can be generalized or limited to renal tissue. As far as secondary AI is concerned, ACTH deficiency may be isolated or, in the majority of cases, combined in the context of combined pituitary hormonal deficiency, with wide clinical spectrum and genetic heterogeneity, mainly related to mutations in genes expressed in the developing head, hypothalamus, and/or pituitary.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  • Arnhold IJ, França MM, Carvalho LR, Mendonca BB, et al. Role of GLI2 in hypopituitarism phenotype. J Mol Endocrinol. 2015;54(3):R141–50.

    Article  CAS  PubMed  Google Scholar 

  • Auchus RJ. Steroid 17-hydroxylase and 17,20-lyase deficiencies, genetic and pharmacologic. J Steroid Biochem Mol Biol. 2017;165(Pt A):71–78.

    Article  CAS  PubMed  Google Scholar 

  • Avbelj Stefanija M, Kotnik P, Bratanič N, Žerjav Tanšek M, et al. Novel Mutations in HESX1 and PROP1 Genes in Combined Pituitary Hormone Deficiency. Horm Res Paediatr. 2015;84(3):153–8.

    Google Scholar 

  • Bizzarri C, Massimi A, Federici L, Cualbu A, et al. A new homozygous frameshift mutation in the HSD3B2 gene in an apparently nonconsanguineous Italian family. Horm Res Paediatr. 2016;86(1):53–61.

    Article  CAS  PubMed  Google Scholar 

  • Bulsari K, Falhammar H. Clinical perspectives in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency. Endocrine. 2017;55(1):19–36.

    Article  CAS  PubMed  Google Scholar 

  • Burkhard FZ, Parween S, Udhane SS, Flück CE, et al. P450 oxidoreductase deficiency: analysis of mutations and polymorphisms. J Steroid Biochem Mol Biol. 2017;165(Pt A):38–50.

    Article  CAS  PubMed  Google Scholar 

  • Camats N, Pandey AV, Fernández-Cancio M, Fernández JM, et al. STAR splicing mutations cause the severe phenotype of lipoid congenital adrenal hyperplasia: insights from a novel splice mutation and review of reported cases. Clin Endocrinol. 2014;80(2):191–9.

    Article  CAS  Google Scholar 

  • Çetinkaya S, Güran T, Kurnaz E, Keskin M, et al. A patient with proopiomelanocortin deficiency: an increasingly important diagnosis to make. J Clin Res Pediatr Endocrinol. 2018;10(1):68–73.

    Article  PubMed  PubMed Central  Google Scholar 

  • Charmandari E, Kino T, Chrousos GP. Primary generalized familial and sporadic glucocorticoid resistance (Chrousos syndrome) and hypersensitivity. Endocr Dev. 2013;24:67–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Charmandari E, Nicolaides NC, Chrousos GP. Adrenal insufficiency. Lancet. 2014;383(9935):2152–67.

    Article  CAS  Google Scholar 

  • Chen W, Xu Z, Sullivan A, Finkielstain GP, et al. Junction site analysis of chimeric CYP21A1P/CYP21A2 genes in 21-hydroxylase deficiency. Clin Chem. 2012;58(2):421–30.

    Article  CAS  PubMed  Google Scholar 

  • Chung TT, Chan LF, Metherell LA, Clark AJ. Phenotypic characteristics of familial glucocorticoid deficiency (FGD) type 1 and 2. Clin Endocrinol. 2010;72(5):589–94.

    Article  CAS  Google Scholar 

  • Concolino P, Costella A. Congenital Adrenal Hyperplasia (CAH) due to 21-hydroxylase deficiency: a comprehensive focus on 233 pathogenic variants of CYP21A2 gene. Mol Diagn Ther. 2018;22(3):261–280.

    Article  CAS  PubMed  Google Scholar 

  • Dubey P, Raymond GV, Moser AB, Kharkar S, et al. Adrenal insufficiency in asymptomatic adrenoleukodystrophy patients identified by very long-chain fatty acid screening. J Pediatr. 2005;146(4):528–32.

    Article  PubMed  Google Scholar 

  • El-Maouche D, Arlt W, Merke DP. Congenital adrenal hyperplasia. Lancet. 2017;390(10108):2194–2210.

    Article  CAS  PubMed  Google Scholar 

  • Engelen M, Barbier M, Dijkstra IM, Schür R, et al. X-linked adrenoleukodystrophy in women: a cross-sectional cohort study. Brain. 2014;137(Pt 3):693–706.

    Article  PubMed  Google Scholar 

  • Falhammar H, Nordenström A. Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome. Endocrine. 2015;50(1):32–50.

    Article  CAS  PubMed  Google Scholar 

  • Fang Q, George AS, Brinkmeier ML, Mortensen AH, et al. Genetics of combined pituitary hormone deficiency: roadmap into the genome era. Endocr Rev. 2016;37(6):636–675.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fleseriu M, Hashim IA, Karavitaki N, Melmed S, et al. Hormonal replacement in hypopituitarism in adults: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(11):3888–3921.

    Article  CAS  PubMed  Google Scholar 

  • Fourcade S, López-Erauskin J, Galino J, Duval C, et al. Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy. Hum Mol Genet. 2008;17(12):1762–73.

    Article  CAS  PubMed  Google Scholar 

  • Fukami M, Ogata T. Cytochrome P450 oxidoreductase deficiency: rare congenital disorder leading to skeletal malformations and steroidogenic defects. Pediatr Int. 2014;56(6):805–808.

    Article  CAS  PubMed  Google Scholar 

  • Fukami M, Nishimura G, Homma K, Nagai T, et al. Cytochrome P450 oxidoreductase deficiency: identification and characterization of biallelic mutations and genotype-phenotype correlations in 35 Japanese patients. J Clin Endocrinol Metab. 2009;94(5):1723–31.

    Article  CAS  PubMed  Google Scholar 

  • Giordano M. Genetic causes of isolated and combined pituitary hormone deficiency. Best Pract Res Clin Endocrinol Metab. 2016;30(6):679–691.

    Article  CAS  PubMed  Google Scholar 

  • Haider S, Islam B, D’Atri V, Sgobba M, et al. Structure-phenotype correlations of human CYP21A2 mutations in congenital adrenal hyperplasia. Proc Natl Acad Sci U S A. 2013;110(7):2605–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hannah-Shmouni F, Chen W, Merke DP. Genetics of congenital adrenal hyperplasia. Endocrinol Metab Clin North Am. 2017;46(2):435–458.

    Article  PubMed  Google Scholar 

  • Hanukoglu I, Rapoport R. Routes and regulation of NADPH production in steroidogenic mitochondria. Endocr Res. 1995;21(1–2):231–41.

    Article  CAS  PubMed  Google Scholar 

  • Hein S, Schönfeld P, Kahlert S, Reiser G. Toxic effects of X-linked adrenoleukodystrophy-associated, very long chain fatty acids on glial cells and neurons from rat hippocampus in culture. Hum Mol Genet. 2008;17(12):1750–61.

    Article  CAS  PubMed  Google Scholar 

  • Higham CE, Johannsson G, Shalet SM. Hypopituitarism. Lancet. 2016;388(10058):2403–2415.

    Article  CAS  PubMed  Google Scholar 

  • Hughes CR, Guasti L, Meimaridou E, Chuang CH, et al. MCM4 mutation causes adrenal failure, short stature, and natural killer cell deficiency in humans. J Clin Invest. 2012;122(3):814–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jazayeri O, Liu X, van Diemen CC, Bakker-van Waarde WM, et al. A novel homozygous insertion and review of published mutations in the NNT gene causing familial glucocorticoid deficiency (FGD). Eur J Med Genet. 2015;58(12):642–9.

    Article  PubMed  Google Scholar 

  • Kemp S, Huffnagel IC, Linthorst GE, Wanders RJ, et al. Adrenoleukodystrophy – neuroendocrine pathogenesis and redefinition of natural history. Nat Rev Endocrinol. 2016;12(10):606–15.

    Article  CAS  PubMed  Google Scholar 

  • Khattab A, Haider S, Kumar A, Dhawan S, et al. Clinical, genetic, and structural basis of congenital adrenal hyperplasia due to 11β-hydroxylase deficiency. Proc Natl Acad Sci USA. 2017;114(10):E1933–E1940.

    Article  CAS  Google Scholar 

  • Kim A, Fujimoto M, Hwa V, Backeljauw P, et al. Adrenal insufficiency, sex reversal, and Angelman syndrome due to uniparental disomy unmasking a mutation in CYP11A1. Horm Res Paediatr. 2018; 89(3):205–210.

    Article  CAS  PubMed  Google Scholar 

  • Krone N, Reisch N, Idkowiak J, Dhir V, et al. Genotype-phenotype analysis in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency. J Clin Endocrinol Metab. 2012;97(2):E257–67.

    Article  CAS  PubMed  Google Scholar 

  • Kruska N, Schönfeld P, Pujol A, Reiser G. Astrocytes and mitochondria from adrenoleukodystrophy protein (ABCD1)-deficient mice reveal that the adrenoleukodystrophy-associated very long-chain fatty acids target several cellular energy-dependent functions. Biochim Biophys Acta. 2015;1852(5):925–36.

    Article  CAS  PubMed  Google Scholar 

  • Lei M. The MCM complex: its role in DNA replication and implications for cancer therapy. Curr Cancer Drug Targets. 2005;5(5):365–80.

    Article  CAS  PubMed  Google Scholar 

  • McCabe MJ, Alatzoglou KS, Dattani MT. Septo-optic dysplasia and other midline defects: the role of transcription factors: HESX1 and beyond. Best Pract Res Clin Endocrinol Metab. 2011;25(1):115–24.

    Article  CAS  PubMed  Google Scholar 

  • McCammon KM, Panda SP, Xia C, Kim JJ, et al. Instability of the human cytochrome P450 reductase A287P variant is the major contributor to its Antley-Bixler syndrome-like phenotype. J Biol Chem. 2016;291(39):20487–502.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • McCann KL, Teramoto T, Zhang J, Tanaka Hall TM, et al. The molecular basis for ANE syndrome revealed by the large ribosomal subunit processome interactome. Elife. 2016;5. pii: e16381.

    Google Scholar 

  • Meimaridou E, Hughes CR, Kowalczyk J, Guasti L, et al. Familial glucocorticoid deficiency: new genes and mechanisms. Mol Cell Endocrinol. 2013;371(1–2):195–200.

    Article  CAS  PubMed  Google Scholar 

  • Meimaridou E, Goldsworthy M, Chortis V, Fragouli E, et al. NNT is a key regulator of adrenal redox homeostasis and steroidogenesis in male mice. J Endocrinol. 2018;236(1):13–28.

    Article  CAS  PubMed  Google Scholar 

  • Miller WL. The syndrome of 17,20 lyase deficiency. J Clin Endocrinol Metab. 2012;97(1):59–67.

    Article  CAS  Google Scholar 

  • Miller WL. Disorders in the initial steps of steroid hormone synthesis. J Steroid Biochem Mol Biol. 2017;165(Pt A):18–37.

    Article  CAS  PubMed  Google Scholar 

  • Moser HW, Moser AB, Frayer KK, Chen W, et al. Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids. Neurology. 1981;31(10):1241–9.

    Article  CAS  PubMed  Google Scholar 

  • Murphy C, Allen L, Jamieson MA. Ambiguous genitalia in the newborn: an overview and teaching tool. J Pediatr Adolesc Gynecol. 2011;24(5):236–50.

    Article  PubMed  Google Scholar 

  • New MI, Abraham M, Gonzalez B, Dumic M, et al. Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Proc Natl Acad Sci U S A. 2013;110(7):2611–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nousbeck J, Spiegel R, Ishida-Yamamoto A, Indelman M, et al. Alopecia, neurological defects, and endocrinopathy syndrome caused by decreased expression of RBM28, a nucleolar protein associated with ribosome biogenesis. Am J Hum Genet. 2008;82(5):1114–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pandey AV, Flück CE. NADPH P450 oxidoreductase: structure, function, and pathology of diseases. Pharmacol Ther. 2013;138(2):229–54.

    Article  CAS  PubMed  Google Scholar 

  • Pang S. Congenital adrenal hyperplasia owing to 3 beta-hydroxysteroid dehydrogenase deficiency. Endocrinol Metab Clin North Am. 2001;30(1):81

    Google Scholar 

  • Panzer K, Ekhaguere OA, Darbro B, Cook J, et al. Uniparental isodisomy of chromosome 1 unmasking an autosomal recessive 3-beta hydroxysteroid dehydrogenase type II-related congenital adrenal hyperplasia. J Clin Res Pediatr Endocrinol. 2017;9(1):70–73.

    Article  PubMed  PubMed Central  Google Scholar 

  • Parween S, Roucher-Boulez F, Flück CE, Lienhardt-Roussie A, et al. P450 oxidoreductase deficiency: loss of activity caused by protein instability from a novel L374H mutation. J Clin Endocrinol Metab. 2016;101(12):4789–4798.

    Article  CAS  PubMed  Google Scholar 

  • Patt H, Koehler K, Lodha S, Jadhav S, et al. Phenotype-genotype spectrum of AAA syndrome from Western India and systematic review of literature. Endocr Connect. 2017;6(8):901–913.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Riepe FG. Pseudohypoaldosteronism. Endocr Dev. 2013;24:86–95.

    Article  CAS  PubMed  Google Scholar 

  • Rubtsov P, Nizhnik A, Dedov I, Kalinchenko N, et al. Partial deficiency of 17α-hydroxylase/17,20-lyase caused by a novel missense mutation in the canonical cytochrome heme-interacting motif. Eur J Endocrinol. 2015;172(5):K19–25.

    Article  CAS  PubMed  Google Scholar 

  • Sahakitrungruang T, Tee MK, Blackett PR, Miller WL. Partial defect in the cholesterol side-chain cleavage enzyme P450scc (CYP11A1) resembling nonclassic congenital lipoid adrenal hyperplasia. J Clin Endocrinol Metab. 2011;96(3):792–8.

    Article  CAS  PubMed  Google Scholar 

  • Sarathi V, Shah NS. Triple-A syndrome. Adv Exp Med Biol. 2010;685:1–8.

    Article  CAS  PubMed  Google Scholar 

  • Sherbet DP, Tiosano D, Kwist KM, Hochberg Z, et al. CYP17 mutation E305G causes isolated 17,20-lyase deficiency by selectively altering substrate binding. J Biol Chem. 2003;278(49):48563–9.

    Article  CAS  PubMed  Google Scholar 

  • Shimada A, Takagi M, Nagashima Y, Miyai K, et al. A Novel Mutation in OTX2 Causes Combined Pituitary Hormone Deficiency, Bilateral Microphthalmia, and Agenesis of the Left Internal Carotid Artery. Horm Res Paediatr. 2016;86(1):62–9.

    Google Scholar 

  • Simard J, Ricketts ML, Gingras S, Soucy P, et al. Molecular biology of the 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene family. Endocr Rev. 2005;26(4):525–82.

    Article  CAS  PubMed  Google Scholar 

  • Speiser PW, Azziz R, Baskin LS, Ghizzoni L, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95(9):4133–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Speiser PW, Arlt W, Auchus RJ, Baskin LS, et al. Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinolo Metab 2018;103(11):4043–4088

    Article  Google Scholar 

  • Spiegel R, Shalev SA, Adawi A, Sprecher E, et al. ANE syndrome caused by mutated RBM28 gene: a novel etiology of combined pituitary hormone deficiency. Eur J Endocrinol. 2010;162(6):1021–5.

    Article  CAS  PubMed  Google Scholar 

  • Suntharalingham JP, Buonocore F, Duncan AJ, Achermann JC. DAX-1 (NR0B1) and steroidogenic factor-1 (SF-1, NR5A1) in human disease. Best Pract Res Clin Endocrinol Metab. 2015;29(4):607–19.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Takagi M, Takahashi M, Ohtsu Y, Sato T, et al. A novel mutation in HESX1 causes combined pituitary hormone deficiency without septo optic dysplasia phenotypes. Endocr J. 2016;63(4):405–10

    Google Scholar 

  • Tajima T, Morikawa S, Nakamura A. Clinical features and molecular basis of pseudohypoaldosteronism type 1. Clin Pediatr Endocrinol. 2017;26(3):109–117.

    Article  PubMed  PubMed Central  Google Scholar 

  • Webb EA, Krone N. Current and novel approaches to children and young people with congenital adrenal hyperplasia and adrenal insufficiency. Best Pract Res Clin Endocrinol Metab. 2015;29(3):449–68.

    Article  PubMed  Google Scholar 

  • Whitcomb RW, Linehan WM, Knazek RA. Effects of long-chain, saturated fatty acids on membrane microviscosity and adrenocorticotropin responsiveness of human adrenocortical cells in vitro. J Clin Invest. 1988;81(1):185–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • White PC. Aldosterone synthase deficiency and related disorders. Mol Cell Endocrinol. 2004;217(1–2):81–7.

    Article  CAS  PubMed  Google Scholar 

  • Woods KS, Cundall M, Turton J, Rizotti K, et al. Over- and underdosage of SOX3 is associated with infundibular hypoplasia and hypopituitarism. Am J Hum Genet. 2005;76(5):833–49.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yu RN, Ito M, Saunders TL, Camper SA, et al. Role of Ahch in gonadal development and gametogenesis. Nat Genet. 1998;20(4):353–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Università Federico II di Napoli, Naples, Italy

    Rosario Pivonello, Chiara Simeoli, Rosario Ferrigno, Maria Cristina De Martino, Davide Menafra, Cristina De Angelis & Annamaria Colao

Authors
  1. Rosario Pivonello
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chiara Simeoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rosario Ferrigno
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maria Cristina De Martino
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Davide Menafra
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Cristina De Angelis
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Annamaria Colao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rosario Pivonello .

Editor information

Editors and Affiliations

  1. Neuroendocrine Unit, University of Naples Federico II Neuroendocrine Unit, Naples, Italy

    Annamaria Colao

  2. Dept. Experimental Medicine, University of L'Aquila Dept. Experimental Medicine, L'Aquila, Italy

    Marie-Lise Jaffrain-Rea

  3. Department of Endocrinology, Centre Hospitalier Universitaire de Lièg Department of Endocrinology, Liège, Belgium

    Albert Beckers

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Pivonello, R. et al. (2019). Genetic Heterogeneity in Adrenal Insufficiency. In: Colao, A., Jaffrain-Rea, ML., Beckers, A. (eds) Polyendocrine Disorders and Endocrine Neoplastic Syndromes. Endocrinology. Springer, Cham. https://doi.org/10.1007/978-3-319-73082-0_5-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-73082-0_5-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-73082-0

  • Online ISBN: 978-3-319-73082-0

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation